Health Care • Medical/Nursing Services
$42.48 ▲ +0.32
(+0.76%)
MKT CAP: $1.48B • VOL: 369.3K
52W L $22 52W H $43
PNTG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $947.7M | $695.2M | $544.9M |
| YoY Revenue Growth % | +36.3% | +27.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $51.9M | $38.1M | $25.2M |
| Operating Margin % | 5.5% | 5.5% | 4.6% |
| Net Income (GAAP) | $29.6M | $22.6M | $13.4M |
| EBITDA (Normalized) | $61.5M | $45.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $48.3M | $39.3M | $33.1M |
| Capital Expenditures (CapEx) | $12.0M | $9.0M | — |
| Free Cash Flow (FCF) | $36.3M | $30.3M | $33.1M |
| FCF Margin % | 3.8% | 4.4% | 6.1% |
| Return on Invested Capital (ROIC %) | 11.0% | 9.7% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $374.3M | $312.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PNTG.